IL6 and COVID-19: Individuals in cohort one with acute COVID-19 had coagulopathy (with increased D-Dimer and fibrinogen), a marked pro-inflammatory response (elevated CRP, IL-6, TNF-α, IL-8 and IL-1β) and lymphopenia, with an increase in the neutrophil: lymphocyte ratio.